In recent news, British American Tobacco (BAT) plans to acquire a nearly 20% stake in the Canadian cannabis producer, Organigram, for about $175.81 million, as reported by CNBC. This investment solidifies BAT’s position as Organigram’s largest shareholder, marking a strategic move in the evolving cannabis industry landscape.
Kingsley Wheaton, BAT’s Chief Marketing Officer, highlighted the potential of CBD as “an exciting growth area” for the company’s future business endeavors, emphasizing BAT’s forward-looking approach and commitment to exploring the expanding cannabis market.
According to BAT’s statement to CNBC, Organigram has shown a strong focus on consumer-led innovation, delivering high-quality recreational and medical cannabis products legally available in Canada. This aligns with BAT’s vision of driving innovation and meeting the evolving needs of consumers within the cannabis sector.
As part of this investment, BAT will appoint two directors to Organigram’s board, further strengthening the collaborative partnership between the two industry leaders. Both BAT and Organigram will pool their scientific and research expertise to establish a Center of Excellence at Organigram’s New Brunswick facility, aiming to drive innovation and product development.
BAT’s diverse portfolio of renowned brands reflects its established presence in the global tobacco market. Additionally, BAT’s foray into non-combustible products underscores its dedication to embracing evolving consumer preferences and emerging product categories.
This strategic investment by BAT comes amidst an industry-wide shift, with other prominent tobacco companies, such as Altria Group, also exploring opportunities within the cannabis space, signaling the growing interest and investment in this rapidly expanding market segment.
In conclusion, BAT’s strengthened partnership with Organigram signifies a significant milestone in the convergence of the tobacco and cannabis industries, underscoring BAT’s commitment to pioneering innovation and shaping the future of the cannabis landscape.
Related on Weedly: Keep exploring the Weedly Glossary, our strain reviews, the Learn hub, our Canada coverage and our USA coverage.
Sources & further reading: For authoritative background see peer-reviewed studies on PubMed, Project CBD, Health Canada, NIDA (US National Institute on Drug Abuse) and the World Health Organization.
The bigger picture
Stories like this one, touching on major tobacco company allocates $175m investment in canadian cannabis brand, are part of a fast-moving cannabis landscape in which policy, science, culture and commerce are all evolving at once. What happens in one market or corner of the industry often ripples outward, influencing consumers, businesses and lawmakers elsewhere. Keeping up with these developments helps readers understand not just isolated headlines but the broader direction of an industry still finding its shape. Cannabis remains a rapidly changing space, and following it closely, from legal shifts to product trends, offers a clearer view of where things may be heading next.
A note on legality and responsible use
Cannabis laws differ dramatically around the world and even between regions of the same country, so the single most important rule is to know and follow the rules where you are. Where cannabis is legal, responsible use means keeping consumption moderate and intentional, storing products safely away from children and pets, and never driving or operating machinery while impaired. Effects vary from person to person depending on dose, tolerance and individual physiology, so a measured, start-low approach is always wise. Treating cannabis with the same care and respect you would any substance helps keep the experience positive and safe.
Related reading on Weedly
- The Weedly cannabis glossary
- More from our News section
- Strain and product reviews
- International cannabis coverage
The bottom line
Topics like major tobacco company allocates $175m investment in canadian cannabis brand are a small part of a large and fast-changing cannabis world, and staying curious and informed is the best way to navigate it. Whether your interest is practical, cultural or simply curiosity, understanding the context behind the subject helps you engage with it more confidently. As always, cannabis is for adults of legal age, laws vary by location, and responsible, moderate use should guide any personal choices. For more coverage across cannabis news, culture, science and the wider world, explore the rest of Weedly and our International section.
Separating fact from myth
Cannabis has long been surrounded by both exaggerated fears and overblown claims, and cutting through that noise is part of engaging with it sensibly. Some widely repeated beliefs do not hold up to scientific scrutiny, while genuine risks and benefits are sometimes overlooked. Relying on credible, evidence-based sources rather than hearsay or marketing helps build an accurate picture. As research continues to mature, our understanding of what cannabis can and cannot do keeps improving, making it worthwhile to stay curious, keep an open mind, and update your knowledge as better information becomes available.
Where to learn more
Cannabis is a broad subject that spans science, law, culture, health and commerce, and there is always more to explore. Building your knowledge over time, from the basics of cannabinoids and terpenes to the details of how laws differ around the world, makes every aspect of the subject easier to navigate. Reliable information is the best tool any consumer or curious reader can have. Explore more of Weedly’s coverage across news, culture, reviews and education to keep learning, and see how the global picture is evolving in our International section.
Understanding cannabis potency and dosing
One of the most useful things any cannabis consumer can understand is potency and dosing. The strength of cannabis products can vary widely, and the amount of THC or CBD present significantly shapes the experience. The widely recommended approach, whether for flower, edibles or concentrates, is to start with a low amount and wait to feel the effects before considering more. This is especially important with edibles, whose onset is delayed and whose effects can be stronger and longer-lasting than expected. Sensible dosing is the single most reliable way to keep any cannabis experience comfortable and under control.
The endocannabinoid system, briefly
Behind cannabis’s effects lies the body’s endocannabinoid system, a network of receptors that helps regulate functions such as mood, appetite, sleep and pain. Cannabis compounds like THC and CBD interact with this system, which is part of why the plant affects people the way it does. This is also why responses vary so much between individuals, since everyone’s physiology differs. A basic awareness of how cannabis works in the body helps consumers set realistic expectations and understand why factors like dose, tolerance and personal chemistry all play a role in shaping the experience.


